Monoclonal antibody ONS-M21 recognizes integrin α3 in gliomas and medulloblastomas

20Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The monoclonal antibody ONS-M21 recognizes an antigen found on the surface of glioma and medulloblastoma cells but does not react with the antigens of normal brain tissue. We purified and identified the 140-kDa protein by means of an antibody-binding affinity column. This 140-kDa antigen has sequences homologous to the amino-terminal region and five paris of the internal domain of integrin α3. When the integrin α3-related sequences was amplified and used to analyse the mRNA of glioma and medulloblastoma surgical specimens, the transcription level of integrin α3 mRNA appeared to be quantitatively correlated with the grade of malignancy. These findings suggest that the ONS-M21 antibody, which reacts with integrin α3, might be useful in the diagnosis of gliomas and medulloblastomas.

Cite

CITATION STYLE

APA

Kishima, H., Shimizu, K., Tamura, K., Miyao, Y., Mabuchi, E., Tominaga, E., … Hayakawa, T. (1999). Monoclonal antibody ONS-M21 recognizes integrin α3 in gliomas and medulloblastomas. British Journal of Cancer, 79(2), 333–339. https://doi.org/10.1038/sj.bjc.6690053

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free